Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-02-19
DOI
10.1093/oncolo/oyac049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis
- (2021) Julie Hallet et al. Journal of the National Comprehensive Cancer Network
- Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
- (2020) Jason S Starr et al. OncoTargets and Therapy
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
- (2020) Thorvardur R. Halfdanarson et al. PANCREAS
- Causes of Death After Neuroendocrine Tumors Diagnosis
- (2020) Mohamad Bassam Sonbol et al. PANCREAS
- Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
- (2020) Annunziata Di Domenico et al. Communications Biology
- Epidemiologic Signatures in Cancer
- (2019) H. Gilbert Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
- (2018) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Simron Singh et al. JAMA Oncology
- ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
- (2018) Chang S. Chan et al. Nature Communications
- Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
- (2008) T. R Halfdanarson et al. ENDOCRINE-RELATED CANCER
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now